GEFITINIB

8990 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking GEFITINIB:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 1824
1 DRUG RESISTANCE 1253
2 DIARRHOEA 907
3 DEATH 758
4 RASH 643
5 DISEASE PROGRESSION 462
6 INTERSTITIAL LUNG DISEASE 420
7 NAUSEA 380
8 METASTASES TO CENTRAL NERVOUS SYSTEM 377
9 DYSPNOEA 332
See all common reactions for GEFITINIB

GEFITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED 9 0.6429
1 PRIDE SYNDROME 8 0.4211
2 EGFR GENE MUTATION 130 0.3476
3 HER2 GENE AMPLIFICATION 3 0.2000
4 ACQUIRED GENE MUTATION 259 0.1976
5 MALIGNANT TRANSFORMATION 70 0.1559
6 SARCOMATOID CARCINOMA 6 0.1034
7 BRAF V600E MUTATION POSITIVE 4 0.0656
8 NON-SMALL CELL LUNG CANCER RECURRENT 18 0.0636
9 METASTASES TO MENINGES 118 0.0518
See all enriched reactions for GEFITINIB